Search For "drug control"
ED attaches assets worth over Rs 2 crore of former deputy drug controller
Updated : 4 years, 1 month ago IST
New Delhi [India], January 14 (ANI): The Enforcement Directorate (ED) has attached assets worth Rs 2.07 crore of a former Deputy Drug Controller Licensing Authority Solan, Himachal Pradesh, and others in a disproportionate asset case.
Read More
Bharat Biotech gets SEC approval for phase 3 clinical trials of COVID boos
Updated : 4 years, 2 months ago IST
New Delhi [India], January 5 (ANI): The Subject Experts Committee (SEC) of the Drug Controller General of India (DCGI) on Wednesday granted approval to Bharat Biotech for conducting intranasal phase 3 trials and heterologous trials for COVID-19 booster intranasal vaccine for those who hav
Read More
SEC to hold meeting on Bharat Biotech's Nasal vaccine booster dose
Updated : 4 years, 2 months ago IST
New Delhi [India], January 4 (ANI): The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) is expected to meet on Tuesday afternoon to discuss Bharat Biotech's application for clinical trials of its intranasal Covid vaccine as a booster or a third dose.
Read More
Dr Dangs Lab as central lab conducted tests in all three trial phases of C
Updated : 4 years, 2 months ago IST
New Delhi [India], December 29 (ANI): With the Drug Controller General of India (DCGI) approving two new COVID-19 vaccines and one anti-viral drug for emergency use on Tuesday, Dr Arjun Dang, CEO, Dr Dangs Lab, welcomed the announcement and said they feel immensely proud "to have been a p
Read More
Biological E gets approval to conduct trials of Corbevax as booster dose
Updated : 4 years, 2 months ago IST
New Delhi [India], December 29 (ANI): The Drug Controller General of India (DCGI) has given approval to the Hyderbad-based pharmaceutical company Biological E to conduct phase 3 clinical trials of its COVID-19 vaccine Corbevax as a booster dose, said sources.
Read More
DCGI grants Cipla emergency use authorisation for COVID-19 drug Molnupirav
Updated : 4 years, 2 months ago IST
Mumbai (Maharashtra) [India], December 28 (ANI): Drug Controller General of India (DCGI) on Tuesday granted Emergency Use Authorisation (EUA) to Cipla for the launch of Molnupiravir in the country for COVID-19 treatment.
Read More
"No knowledge" of whether Gautam Gambhir distributing life-saving medicine
Updated : 4 years, 3 months ago IST
New Delhi [India], December 8 (ANI): Delhi Drugs Control Department has submitted in Delhi High Court that "it is beyond their knowledge" that distribution of life-saving drugs 'Favipiravir' is for "charitable purpose or political gain."
Read More
Zydus seeks DCGI nod for 'Desidustat' oral pill to treat anaemia in kidney
Updated : 4 years, 3 months ago IST
Ahmedabad (Gujarat) [India], November 23 (ANI): Pharmaceutical company Zydus Cadila on Tuesday announced that it has submitted its first "New Drug Application (NDA)" to the Drug Controller General of India for its oral pill "Desidustat" to treat anaemia in kidney patients.
Read More
United States Senate confirms Dr Rahul Gupta as Director of National Drug
Updated : 4 years, 4 months ago IST
Washington [US], October 30 (ANI): The United States Senate on Thursday (local time) confirmed Dr Rahul Gupta to serve as the director of the Office of National Drug Control Policy on a bipartisan basis, White House said in a statement.
Read More
Approval to Covaxin for children aged between 2-18 years awaited after eva
Updated : 4 years, 5 months ago IST
New Delhi [India], October 12 (ANI): After the evaluation of data Covaxin is yet to get approval by the Drugs Controller General of India (DCGI) for children between 2-18 years old, according to official sources.
Read More
Gujarat Food and Drug Control Administration launches Portal Ayudmla durin
Updated : 4 years, 5 months ago IST
Ahmedabad (Gujarat) [India], September 24 (ANI/PNN): Gujarat becomes the First State to launch such an initiative towards Online Licensing, Product Approvals, and Digitisation of Records.
Read More
Sputnik Light Covid vaccine gets permission for Phase 3 trials in India
Updated : 4 years, 6 months ago IST
New Delhi [India], September 15 (ANI): The Drug Controller General of India has given its approval to the single-dose COVID-19 vaccine version of the Sputnik V vaccine 'Sputnik Light' to conduct trials on the Indian population to check whether the vaccine gives a similar immune response i
Read More